NIH Selects BlueInGreen To Test New Technology For Efficient Removal Of Pharmaceuticals From...

BlueInGreen, an Arkansas-based company that provides systems for dissolved gas treatment of water systems, announced a two-year, $750,000 grant from the National Institute of Environmental Health Sciences, a division of the National Institutes of Health, to study the cost-effective removal of pharmaceutical residuals from wastewater using a new hyper ozonation technology. "Without a doubt, the widespread media attention and heightened public awareness surrounding the presence of pharmaceuticals throughout the environment has sparked growing concerns nationwide," said Charlotte Smith, president of PharmEcology, a company that provides environmental consultation to the healthcare industry. "This study is an important first step in removing pharmaceuticals generated by human activity at the most concentrated point of generation.... [read full story]